U
IOSP icon

UBS’s Innospec IOSP Stock Holding History

UBS’s Portfolio IOSP Stock Details IOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-500
Closed -$22K – 10533
2014
Q2 		$22K Buy
+500
New +$21.5K ﹤0.01% 7949

Other funds holding IOSP

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's IOSP Position: Q3 2014 in Review

UBS increased its Innospec (IOSP) stake by 0.72% in Q3 2014, buying an estimated $1.01K and bringing the position to 3,491 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #5705.

UBS first reported a position in IOSP in Q2 2013 and has held it in 6 quarters since. The position peaked at $149K in Q2 2014. 103 funds tracked by Wall St. Rank hold IOSP as of Q3 2014.

  • UBS held 3,491 shares of Innospec worth $126K as of Q3 2014.
  • UBS bought 25 Innospec shares in Q3 2014, an estimated $1.01K.
  • Innospec made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5705 holding.
  • UBS first reported a position in Innospec in Q2 2013 and has held it in 6 quarters since.
  • UBS's Innospec position peaked at $149K in Q2 2014.
  • 103 funds tracked by Wall St. Rank held Innospec as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.